Gene · 910
Papers2,023
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,023
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and verification of a combined immune- and cancer-associated fibroblast related prognostic signature for colon adenocarcinoma. | Front Immunol | 2024 | 38312843 | PubTator, text mining | PubMed |
| Prognosis and immunotherapy response prediction based on M2 macrophage-related genes in colon cancer. | J Cancer Res Clin Oncol | 2024 | 38270646 | PubTator, text mining | PubMed |
| Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy. | Biomolecules | 2024 | 38254683 | PubTator, text mining | PubMed |
| Single-cell landscape identifies the immunophenotypes and microenvironments of HBV-positive and HBV-negative liver cancer. | Hepatol Commun | 2024 | 38251896 | PubTator, text mining | PubMed |
| The roles of tissue resident macrophages in health and cancer. | Exp Hematol Oncol | 2024 | 38229178 | PubTator, text mining | PubMed |
| Pyroptotic cell death: an emerging therapeutic opportunity for radiotherapy. | Cell Death Discov | 2024 | 38228635 | PubTator, text mining | PubMed |
| Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes. | BMC Cancer | 2024 | 38166691 | PubTator, text mining | PubMed |
| Structural Heterogeneity in a Phototransformable Fluorescent Protein Impacts its Photochemical Properties. | Adv Sci (Weinh) | 2024 | 38146132 | PubTator, text mining | PubMed |
| Transcriptionally activates CCL28 expression to inhibit M2 polarization of macrophages and prevent immune escape in colorectal cancer cells. | Transl Oncol | 2024 | 38035446 | PubTator, text mining | PubMed |
| A prognostic model based on tumor microenvironment and immune cell in colorectal cancer. | Scand J Gastroenterol | 2024 | 37978827 | PubTator, text mining | PubMed |
| CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy. | Ann Hematol | 2024 | 37917373 | PubTator, text mining | PubMed |
| Effect of Mycolic Acids on Host Immunity and Lipid Metabolism. | Int J Mol Sci | 2023 | 38203570 | PubTator, text mining | PubMed |
| Interorgan communication with the liver: novel mechanisms and therapeutic targets. | Front Immunol | 2023 | 38155961 | PubTator, text mining | PubMed |
| The Eradication of Carcinogenic Viruses in Established Solid Cancers. | J Inflamm Res | 2023 | 38145011 | PubTator, text mining | PubMed |
| Natural Killer T Cell Diversity and Immunotherapy. | Cancers (Basel) | 2023 | 38136283 | PubTator, text mining | PubMed |
| Identifying CD1c as a potential biomarker by the comprehensive exploration of tumor mutational burden and immune infiltration in diffuse large B cell lymphoma. | PeerJ | 2023 | 38099311 | PubTator, text mining | PubMed |
| Case Report: Identification of novel CDH2 mutation (p. P183A het)-induced arrhythmogenic cardiomyopathy in China. | Front Cardiovasc Med | 2023 | 38075981 | PubTator, text mining | PubMed |
| Exploration of the Conformational Scenario for α-, β-, and γ-Cyclodextrins in Dry and Wet Conditions, from Monomers to Crystal Structures: A Quantum-Mechanical Study. | Int J Mol Sci | 2023 | 38069149 | PubTator, text mining | PubMed |
| Bacterial microbiome and host inflammatory gene expression in foreskin tissue. | Heliyon | 2023 | 38053902 | PubTator, text mining | PubMed |
| Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions. | J Immunother Cancer | 2023 | 38040419 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/910/papers?page=3